InMode (INMD) Chief Executive Moshe Mizrahy on Thursday disputed claims by activist investor DOMA Perpetual Capital Management that it returns capital inefficiently to shareholders and needs to execute a tender offer for 30% of the company's shares
"InMode is exploring, in consultation with financial, legal, and tax advisors, the possibility of returning significant additional capital by the end of 2025 to further enhance shareholder value," the company said.
The Israeli medical devices company also disputed the accusation that InMode has left a crucial sales management position empty as "inaccurate and false."
InMode did not immediately reply to MT Newswires' request for comment.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。